Sabra Health Care REIT Q1 2023 Earnings Report
Key Takeaways
Sabra Health Care REIT reported a net loss of $(0.04) per diluted common share for Q1 2023. However, the company's FFO, Normalized FFO, AFFO, and Normalized AFFO were $0.32, $0.33, $0.33, and $0.34 per diluted common share, respectively. The company also made strategic acquisitions and dispositions of healthcare facilities during the quarter.
Net loss per diluted common share was $(0.04).
FFO per diluted common share was $0.32, Normalized FFO was $0.33, AFFO was $0.33, and Normalized AFFO was $0.34.
Closed on the acquisition of senior housing managed and leased communities with estimated stabilized cash yields of 8.0%.
Generated $190.0 million of gross proceeds from the disposition of skilled nursing and senior housing facilities.
Sabra Health Care REIT
Sabra Health Care REIT
Sabra Health Care REIT Revenue by Segment
Forward Guidance
Sabra anticipates a relatively quiet year, positioning the company to constructively move forward as the industry continues to recover from the pandemic and expects to return to earnings growth in 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income